[INQ. NO. 1503C26] Green Cross Laboratories (GC Labs), established in 1982, is a Korea’s 1st and leading reference laboratory which provides clinical and anatomic pathology testing. We are the largest and the fastest growing reference laboratory in Korea with the revenue of 100 million US dollars in 2014 and 30% domestic market share, serving more than 90% of university hospitals.
GC Labs makes a ceaseless effort to provide the accurate and qualified results to our customers with international accreditations and world-class laboratory system.
Around 600 employees including 20 medical doctors at GC Labs offer more than 4,000 tests and test combinations, ranging from routine tests to highly esoteric molecular and genetic assays, and approximately 30 million tests are performed in GC Labs annually.
With more than 30 years of accumulated know-how, we continue to focus on developing complex clinical testing areas and also to acquire the latest technology and equipment.
We promise not only to be a market leader in Korea but also to become a leading global clinical testing laboratory.
Test Specialty – Institute of Metabolism
– In possession of the highest numbers of experienced personnel and high-end cutting edge analyzers (LCMS/ MS, ICP-MS, AAS, etc.) among the reference laboratories in Korea
– Performs neonatal screening test, metabolic and nutritional profiles, environmental toxicant assay, esoteric enzyme assay, pharmacokinetics study – The only reference laboratory in Korea that conducts the enzyme activity test, a specialized biochemical confirmation test that is a part of our test for inherited metabolic disorders.
– Holds a patent for “A method for analyzing tandem-mass data for clinical diagnosis” for the first time in Korea in our extensive inherited metabolic disorder test in newborns.
Cytogenetics and Molecular Genetics
– Delivers a complete range of genetics tests by using the most advanced technology, such as Next Generation Sequencing analysis (NGS), microarray, gene scan, automated sequencing, pyrosequencing, Luminex technology, MLPA (multiplex ligation-dependent probe amplification)
– Performs Cancer-related genetic test, hereditary disease, prenatal diagnosis, chromosomal microarray, chromosomal analysis, infectious disease, pharmacogenetic tests, histocompatibility tests, forensic tests
Clinical Trial
– Experts on clinical trials and experiments help researchers in developing new drugs and clinical trials (phase I, II, III, IV), investigator initiated trials, sponsor initiated trials, and experiments for research papers, collaborating with CRO’s in Korea and overseas
– Exclusive program for clinical trial: Separate specimen processing system (isolated room, separate equipment and instruments, project-specific electronic operating system operated by highly trained experts) from routine clinical samples, from pre-analytical to post-analytical stage
Laboratory Medicine
– Korea’s first and the largest Total Laboratory Automation System (TLA) was built using the latest technology, helping us to maximize efficiency by cutting down on turnaround time and lowering laboratory error rates
– Offers accurate and rapid results 24 hours a day, for the widest range of hematology, chemistry, immunology and microbiology tests to diagnose various diseases, syndromes and conditions
Pathology
– Conducts screening and confirm tests and expert reading for all biopsy or surgery samples, body fluid (urine, mucus, peritoneal fluid, pleural fluid, etc.), needle aspiration (thyroid, breast, etc.) and uterovaginal smear specimens.
– Provides the state-of-the-art technologies for immunohistochemical staining and cutting edge molecular pathology tests
Korean-Products.com | Blog Magazine of Korean products, brands and Goods
